Find your next role
Strengthen your profile
Definium Therapeutics
Biotechnology
See how your profile stacks up against this role.
We compared the job requirements to your profile to show where you're strong and where you fall short.
Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale.
Our lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges.
Guided by the recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address the underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today’s mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX.
Together we are moving psychiatry forward—beyond better, into a boundless future. Join us!
As Definium Therapeutics approaches a pivotal commercial launch for DT120, we are seeking a hands-on Senior Director, Site Engagement & Field Reimbursement to build and lead the field organization responsible for readying treatment sites to deliver DT120 and securing their reimbursement pathway once live. Reporting to the Vice President of Market Access, this role owns both halves of the equation that determines whether a site can treat patients: the ability to operationalize DT120, and the ability to secure adequate reimbursement.
Responsibilities include but not limited to the following:
Qualifications:
The starting base pay range for this position is $250,000.00 - $295,000.00. Compensation will be determined based on several factors including, but not limited to, skill set, years of experience, and the employee’s geographic location.
Employees in this role may be entitled to additional compensation, including bonus and equity. Benefits information is listed on our Jobs Page. The Company provides competitive benefits to employees including:
After you apply, unlock the direct contact details of the people who actually make the call. A quick follow-up makes you 5x more likely to land an interview.
Marcus Rivera
Chief Revenue Officer

Sunrise

PatientNow

HistoSonics, Inc.

Circular Action Alliance

Envision Healthcare

Definium Therapeutics

Definium Therapeutics

Definium Therapeutics